- Home
- TS vs IQV Comparison
TS vs IQV Comparison
Compare TS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TS
- IQV
- Stock Information
- Founded
- TS 2001
- IQV 1982
- Country
- TS Luxembourg
- IQV United States
- Employees
- TS N/A
- IQV N/A
- Industry
- TS Steel/Iron Ore
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TS Industrials
- IQV Health Care
- Exchange
- TS Nasdaq
- IQV Nasdaq
- Market Cap
- TS 22.7B
- IQV 24.9B
- IPO Year
- TS N/A
- IQV 2013
- Fundamental
- Price
- TS $34.06
- IQV $148.92
- Analyst Decision
- TS Strong Buy
- IQV Buy
- Analyst Count
- TS 5
- IQV 20
- Target Price
- TS $45.20
- IQV $230.55
- AVG Volume (30 Days)
- TS 1.7M
- IQV 2.0M
- Earning Date
- TS 04-30-2025
- IQV 05-06-2025
- Dividend Yield
- TS 3.23%
- IQV N/A
- EPS Growth
- TS N/A
- IQV 0.26
- EPS
- TS 1.63
- IQV 7.35
- Revenue
- TS $12,004,602,000.00
- IQV $15,497,000,000.00
- Revenue This Year
- TS N/A
- IQV $4.08
- Revenue Next Year
- TS $1.72
- IQV $5.88
- P/E Ratio
- TS $10.01
- IQV $20.37
- Revenue Growth
- TS N/A
- IQV 2.84
- 52 Week Low
- TS $27.24
- IQV $135.97
- 52 Week High
- TS $40.87
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- TS 50.23
- IQV 42.96
- Support Level
- TS $32.97
- IQV $143.65
- Resistance Level
- TS $33.93
- IQV $156.50
- Average True Range (ATR)
- TS 0.70
- IQV 5.66
- MACD
- TS 0.26
- IQV 1.46
- Stochastic Oscillator
- TS 94.65
- IQV 59.49
About TS Tenaris S.A.
Tenaris is one of the largest global producers of oil country tubular goods, which are used primarily in the construction of oil and gas wells. Its production facilities are located primarily in the U.S., Argentina, Mexico, and Italy. Tenaris' premium OCTG products are among the most trusted by oil companies for use in the most challenging applications, including deep-water offshore wells and horizontal shale wells.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.